Avadel Pharmaceuticals (AVDL) Short Interest Ratio & Short Volume → AI “wealth window” is closing June 25th (From Paradigm Press) (Ad) Free AVDL Stock Alerts $16.25 -1.93 (-10.62%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Avadel Pharmaceuticals Short Interest DataCurrent Short Volume10,610,000 sharesPrevious Short Volume10,390,000 sharesChange Vs. Previous Month+2.12%Dollar Volume Sold Short$0.00Short Interest Ratio / Days to Cover8.7Last Record DateApril 15, 2024Outstanding Shares90,577,000 sharesPercentage of Shares Shorted11.71%Today's Trading Volume4,207,070 sharesAverage Trading Volume1,219,241 sharesToday's Volume Vs. Average345% Short Selling Avadel Pharmaceuticals ? Sign up to receive the latest short interest report for Avadel Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAVDL Short Interest Over TimeAVDL Days to Cover Over TimeAVDL Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself Avadel Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202410,610,000 shares $0.00 +2.1%N/A8.7 $0.00 3/31/202410,390,000 shares $175.49 million -0.8%N/A8.4 $16.89 3/15/202410,470,000 shares $166.68 million -2.5%N/A8.2 $15.92 2/29/202410,740,000 shares $137.26 million +21.2%N/A8.5 $12.78 2/15/20248,860,000 shares $125.81 million +4.5%N/A9.2 $14.20 1/31/20248,480,000 shares $122.03 million +30.1%N/A9.2 $14.39 Get the Latest News and Ratings for AVDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avadel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20246,520,000 shares $96.50 million +26.6%N/A7.7 $14.80 12/31/20235,150,000 shares $72.72 million +2.2%N/A6.8 $14.12 12/15/20235,040,000 shares $70.51 million +6.1%N/A7.5 $13.99 11/30/20234,750,000 shares $54.82 million -0.4%N/A7.6 $11.54 11/15/20234,770,000 shares $52.09 million +19.3%N/A8.3 $10.92 10/31/20234,000,000 shares $39.44 million +4.4%N/A6.9 $9.86 10/15/20233,830,000 shares $40.29 million +0.8%N/A6.8 $10.52 9/30/20233,800,000 shares $39.14 million +13.8%N/A6.6 $10.30 9/15/20233,340,000 shares $40.98 million +28.0%N/A5 $12.27 8/31/20232,610,000 shares $35.26 million -15.3%N/A3.5 $13.51 8/15/20233,080,000 shares $42.38 million -1.0%N/A3.9 $13.76 7/31/20233,110,000 shares $43.85 million -8.5%N/A3.7 $14.10 7/15/20233,400,000 shares $52.33 million -8.6%N/A3.4 $15.39 6/30/20233,720,000 shares $61.31 million -21.4%N/A3.8 $16.48 6/15/20234,730,000 shares $70.00 million +16.8%N/A4.6 $14.80 5/31/20234,050,000 shares $56.09 million +20.9%N/A4.4 $13.85 5/15/20233,350,000 shares $48.61 million -13.9%N/A3.7 $14.51 4/30/20233,890,000 shares $40.77 million +4.6%N/A4.5 $10.48 4/15/20233,720,000 shares $36.87 million +24.0%N/A5.8 $9.91 3/31/20233,000,000 shares $27.48 million -24.1%N/A4.9 $9.16 3/15/20233,950,000 shares $36.26 million -0.3%6.9%9 $9.18 2/28/20233,960,000 shares $39.40 million +0.3%7.3%7.9 $9.95 2/15/20233,950,000 shares $33.58 million +7.9%7.2%7.5 $8.50 1/31/20233,660,000 shares $27.54 million +9.6%6.5%6.1 $7.53 1/15/20233,340,000 shares $22.98 million -17.5%5.9%5.4 $6.88 12/30/20224,050,000 shares $29.00 million +3.3%7.1%6.8 $7.16 12/15/20223,920,000 shares $26.93 million +0.8%6.9%5.3 $6.87 11/30/20223,890,000 shares $35.67 million -2.5%6.9%5.7 $9.17 11/15/20223,990,000 shares $32.12 million -1.0%7.0%6.1 $8.05 10/31/20224,030,000 shares $26.56 million -1.2%7.3%7 $6.59 10/15/20224,080,000 shares $24.60 million +7.9%7.4%6.7 $6.03 9/30/20223,780,000 shares $18.94 million -4.6%6.9%5.3 $5.01 9/15/20223,960,000 shares $23.64 million +2.1%7.2%5.4 $5.97 8/31/20223,880,000 shares $25.76 million -14.0%7.1%4.8 $6.64Elon Musk Secret Crypto Plot Exposed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. AVDL Short Interest - Frequently Asked Questions What is Avadel Pharmaceuticals' current short interest? Short interest is the volume of Avadel Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 10,610,000 shares of AVDL short. Learn More on Avadel Pharmaceuticals' current short interest. What is a good short interest ratio for Avadel Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVDL shares currently have a short interest ratio of 9.0. Learn More on Avadel Pharmaceuticals's short interest ratio. Which institutional investors are shorting Avadel Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Avadel Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Avadel Pharmaceuticals' short interest increasing or decreasing? Avadel Pharmaceuticals saw a increase in short interest in April. As of April 15th, there was short interest totaling 10,610,000 shares, an increase of 2.1% from the previous total of 10,390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Avadel Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Avadel Pharmaceuticals: Zai Lab Limited (4.11%), Kura Oncology, Inc. (15.93%), Taro Pharmaceutical Industries Ltd. (0.58%), Supernus Pharmaceuticals, Inc. (8.93%), Schrödinger, Inc. (8.88%), Dynavax Technologies Co. (14.17%), Akero Therapeutics, Inc. (11.83%), Harmony Biosciences Holdings, Inc. (21.01%), Protagonist Therapeutics, Inc. (6.00%), Morphic Holding, Inc. (12.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Avadel Pharmaceuticals stock? Short selling AVDL is an investing strategy that aims to generate trading profit from Avadel Pharmaceuticals as its price is falling. AVDL shares are trading down $1.93 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Avadel Pharmaceuticals? A short squeeze for Avadel Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AVDL, which in turn drives the price of the stock up even further. How often is Avadel Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVDL, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ZLAB Short Interest KURA Short Interest TARO Short Interest SUPN Short Interest SDGR Short Interest DVAX Short Interest AKRO Short Interest HRMY Short Interest PTGX Short Interest MORF Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVDL) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe #1 Crypto for AIWeiss Ratings